Singapore strengthens clinical trials capacity in collaboration with WHO
Singapore, Sept. 8 -- Based at the Saw Swee Hock School of Public Health, National University of Singapore, ADVANCE-ID is Singapore's 13th World Health Organisation (WHO) collaborating centre and joins a global network of institutions designated to support WHO's mandate.
ADVANCE-ID will support WHO's global health programmes and strategic priorities with a specific focus on advancing high quality, ethically sound, clinical research with a focus on clinical trials, strengthening clinical trial ecosystems and fostering partnerships across countries.
The designation for ADVANCE-ID comes at a time when countries are increasingly recognising the importance of strong clinical research systems, including for clinical trials, in responding to p...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.